| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 4,078 | 4,102 | 27.01. | |
| 4,080 | 4,098 | 27.01. |
| Stück | Geld | Kurs | Brief | Stück |
|---|---|---|---|---|
| 20,000 | 400 | |||
| 12,950 | 375 | |||
| 9,900 | 100 | |||
| 8,000 | 1.350 | |||
| 7,000 | 3.900 | |||
| 6,600 | 200 | |||
| 5,500 | 2.455 | |||
| 5,000 | 900 | |||
| 4,098 | 1.865 | |||
Quelle: [URL] https://aktienkurs-orderbuch.finanznachrichten.de/ayj.htm [/URL] | ||||
| 1.865 | 4,080 | |||
| 1.000 | 3,640 | |||
| 1.068 | 0,000 | |||
| Summe Aktien im Kauf | Verhältnis | Summe Aktien im Verkauf | ||
| 3.933 | 2,935 | 11.545 | ||
| Uhrzeit | Aktienkurs | Stück |
|---|---|---|
| 17:37:49 | 4,098 | 118 |
| 16:19:21 | 3,972 | 24 |
| 16:14:21 | 3,970 | 691 |
| 16:11:07 | 3,954 | 7 |
| 16:11:07 | 3,960 | 253 |
| 16:01:49 | 3,962 | 49 |
| 15:52:19 | 3,976 | 73 |
| 15:50:30 | 3,964 | 107 |
| 15:35:13 | 3,988 | 1 |
| 15:35:13 | 3,974 | 59 |
| 14:30:34 | 3,958 | 400 |
| 14:22:35 | 3,994 | 174 |
| 14:22:35 | 3,994 | 322 |
| 13:05:37 | 3,992 | 15 |
| 12:08:50 | 3,980 | 4 |
| 12:00:57 | 4,002 | 2.622 |
| 10:46:51 | 3,986 | 17 |
| 10:37:07 | 3,994 | 100 |
| 09:42:55 | 3,900 | 3 |
| 09:27:38 | 3,898 | 28 |
| Tagesumsatz Xetra | +0,192 +4,92 % | 7.331 |
Angaben in grüner Schrift zeigen, dass der Aktienkurs im Vergleich zum vorherigen Kurs gestiegen ist. Angaben in roter Schrift zeigen gefallene Börsenkurse.
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Di | Abend-Update: Valneva: Ungewöhnliche Ruhe - steht eine Entscheidung bevor? - nicht verpassen! | Hebelschein-Spekulant | |||
| VALNEVA Aktie jetzt für 0€ handeln | |||||
| Mo | VALNEVA SE - Schwäche mit Signalcharakter | 61 | Maximilian Berger | ||
| 20.01. | Valneva Steps Back From US Approval Bid For Chikungunya Vaccine | 63 | Benzinga.com | ||
| 20.01. | Valneva to withdraw Chikungunya vaccine from US amid safety woes | 55 | BioPharma Dive | ||
| 20.01. | Valneva withdraws chikungunya vaccine Ixchiq from US amid new FDA investigation | 51 | FiercePharma |
| Zeit | Aktuelle Nachrichten | Medien | ||
|---|---|---|---|---|
| Di | Evotec Aktie: Comebacktitel für 2026? | 4investors | Aktionäre von Evotec müssen viel Geduld aufbringen. Seit Monaten scheitern immer wieder die Versuche der Biotech-Aktie, stabil über die 200-Tage-Linie zu springen. An oder knapp oberhalb des viel beachteten... ► Artikel lesen | |
| Di | Psyence Group Inc.: Psyence Group's RTO Target, GoldCoast Resource Corp., Granted Offshore Reconnaissance License for Gold Exploration on Ghana's Shallow Continental Shelf | ACCESS Newswire | TORONTO, ON / ACCESS Newswire / January 27, 2026 / Psyence Group Inc. (CSE:PSYG) ("Psyence" or the "Company") announces that its proposed reverse takeover target, GoldCoast Resource Corp. ("GoldCoast")... ► Artikel lesen | |
| Di | Cytokinetics, Incorporated: Cytokinetics Announces MYQORZO (aficamten) Now Available in the U.S. for the Treatment of Adults with Symptomatic Obstructive Hypertrophic Cardiomyopathy to Improve Functional Capacity and Symptoms | GlobeNewswire (Europe) | MYQORZO, a Cardiac Myosin Inhibitor, Directly Addresses Underlying Hypercontractility Associated with Obstructive HCM SOUTH SAN FRANCISCO, Calif., Jan. 27, 2026 (GLOBE NEWSWIRE) -- Cytokinetics,... ► Artikel lesen | |
| Di | VALBIOTIS SA: 2025 Commercial roll-out underway, reflected in a strong ramp-up in revenues in Q4 | Dow Jones News | DJ VALBIOTIS SA: 2025 Commercial roll-out underway, reflected in a strong ramp-up in revenues in Q4
VALBIOTIS SA
VALBIOTIS SA: 2025 Commercial roll-out underway, reflected in a strong ramp-up in... ► Artikel lesen | |
| Di | Morning Market Movers: Nuwellis, BiomX, Brand Engagement Network, Blaize Holdings See Big Swings | AFX News | WOONSOCKET (dpa-AFX) - At 7:02 a.m. ET on Tuesday, premarket trading is seeing notable activity in several stocks, with early price movements signaling potential opportunities before the opening... ► Artikel lesen |